Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fernandez-Real, J. M.
Right arrow Articles by Ricart, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fernandez-Real, J. M.
Right arrow Articles by Ricart, W.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 49, Issue 3 517-520, Copyright © 2000 by American Diabetes Association


ARTICLES

Interleukin-6 gene polymorphism and insulin sensitivity

JM Fernandez-Real, M Broch, J Vendrell, C Gutierrez, R Casamitjana, M Pugeat, C Richart and W Ricart
Unitat de Diabetologia, Endocrinologia i Nutricio, University Hospital of Girona Dr Josep Trueta, Spain. endocrino@htrueta.scs.es

Type 2 diabetes and the insulin resistance syndrome have been hypothesized to constitute manifestations of an ongoing acute-phase response. We aimed to study an interleukin-6 (IL-6) gene polymorphism in relation to insulin sensitivity (IL-6 is the main cytokine involved in an acute-phase response). Subjects homozygous for the C allele at position -174 of the IL-6 gene (SfaNI genotype), associated to lower plasma IL-6 levels, showed significantly lower integrated area under the curve of serum glucose concentrations (AUCglucose) after an oral glucose tolerance test, lower blood glycosylated hemoglobin, lower fasting insulin levels, lower total and differential white blood cell count (a putative marker of peripheral IL-6 action), and an increased insulin sensitivity index than carriers of the G allele, despite similar age and body composition. A gene dosage effect was especially remarkable for AUCglucose (6.4 vs. 9.3 vs. 9.7 mmol/l in C/C, C/G, and G/G individuals, respectively). The serum concentration of fully glycosylated cortisol binding globulin (another marker of IL-6 action), suggested by concanavalin A adsorption, was lower in C/C subjects than in G/G individuals (32.6+/-2.9 vs. 37.6+/-4.6 mg/l, P = 0.03). In summary, a polymorphism of the IL-6 gene influences the relationship among insulin sensitivity, postload glucose levels, and peripheral white blood cell count.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
L. Qi, N. Rifai, and F. B. Hu
Interleukin-6 Receptor Gene Variations, Plasma Interleukin-6 Levels, and Type 2 Diabetes in U.S. Women
Diabetes, December 1, 2007; 56(12): 3075 - 3081.
[Abstract] [Full Text] [PDF]


Home page
J Bone Joint Surg BrHome page
P. V. Giannoudis, M. van Griensven, E. Tsiridis, and H. C. Pape
The genetic predisposition to adverse outcome after trauma
J Bone Joint Surg Br, October 1, 2007; 89-B(10): 1273 - 1279.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
S. Glund, A. Deshmukh, Y. C. Long, T. Moller, H. A. Koistinen, K. Caidahl, J. R. Zierath, and A. Krook
Interleukin-6 Directly Increases Glucose Metabolism in Resting Human Skeletal Muscle
Diabetes, June 1, 2007; 56(6): 1630 - 1637.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
J. Bamoulid, C. Courivaud, M. Deschamps, P. Mercier, C. Ferrand, A. Penfornis, P. Tiberghien, J.-M. Chalopin, P. Saas, and D. Ducloux
IL-6 Promoter Polymorphism -174 Is Associated with New-Onset Diabetes after Transplantation
J. Am. Soc. Nephrol., August 1, 2006; 17(8): 2333 - 2340.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
L. Qi, R. M. van Dam, J. B. Meigs, J. E. Manson, D. Hunter, and F. B. Hu
Genetic variation in IL6 gene and type 2 diabetes: tagging-SNP haplotype analysis in large-scale case-control study and meta-analysis
Hum. Mol. Genet., June 1, 2006; 15(11): 1914 - 1920.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
A. Oberbach, A. Tonjes, N. Kloting, M. Fasshauer, J. Kratzsch, M. W Busse, R. Paschke, M. Stumvoll, and M. Bluher
Effect of a 4 week physical training program on plasma concentrations of inflammatory markers in patients with abnormal glucose tolerance.
Eur. J. Endocrinol., April 1, 2006; 154(4): 577 - 585.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
O. P. Kristiansen and T. Mandrup-Poulsen
Interleukin-6 and Diabetes: The Good, the Bad, or the Indifferent?
Diabetes, December 1, 2005; 54(suppl_2): S114 - S124.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
M. Cardellini, L. Perego, M. D'Adamo, M. A. Marini, C. Procopio, M. L. Hribal, F. Andreozzi, S. Frontoni, M. Giacomelli, M. Paganelli, et al.
C-174G Polymorphism in the Promoter of the Interleukin-6 Gene Is Associated With Insulin Resistance
Diabetes Care, August 1, 2005; 28(8): 2007 - 2012.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
H. F. Escobar-Morreale, M. Luque-Ramirez, and J. L. San Millan
The Molecular-Genetic Basis of Functional Hyperandrogenism and the Polycystic Ovary Syndrome
Endocr. Rev., April 1, 2005; 26(2): 251 - 282.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
K. F. Petersen, S. Dufour, D. Befroy, M. Lehrke, R. E. Hendler, and G. I. Shulman
Reversal of Nonalcoholic Hepatic Steatosis, Hepatic Insulin Resistance, and Hyperglycemia by Moderate Weight Reduction in Patients With Type 2 Diabetes
Diabetes, March 1, 2005; 54(3): 603 - 608.
[Abstract] [Full Text] [PDF]


Home page
JBJSHome page
C. S. Roberts, H.-C. Pape, A. L. Jones, A. L. Malkani, J. L. Rodriguez, and P. V. Giannoudis
Damage Control Orthopaedics. Evolving Concepts in the Treatment of Patients Who Have Sustained Orthopaedic Trauma
J. Bone Joint Surg. Am., February 1, 2005; 87(2): 434 - 449.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
H. Wang, Z. Zhang, W. Chu, T. Hale, J. J. Cooper, and S. C. Elbein
Molecular Screening and Association Analyses of the Interleukin 6 Receptor Gene Variants with Type 2 Diabetes, Diabetic Nephropathy, and Insulin Sensitivity
J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 1123 - 1129.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
H. Staiger, K. Staiger, N. Stefan, H. G. Wahl, F. Machicao, M. Kellerer, and H.-U. Haring
Palmitate-Induced Interleukin-6 Expression in Human Coronary Artery Endothelial Cells
Diabetes, December 1, 2004; 53(12): 3209 - 3216.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Lappas, M. Permezel, and G. E. Rice
Release of Proinflammatory Cytokines and 8-Isoprostane from Placenta, Adipose Tissue, and Skeletal Muscle from Normal Pregnant Women and Women with Gestational Diabetes Mellitus
J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5627 - 5633.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
T. Illig, F. Bongardt, A. Schopfer, S. Muller-Scholze, W. Rathmann, W. Koenig, B. Thorand, C. Vollmert, R. Holle, H. Kolb, et al.
Significant Association of the Interleukin-6 Gene Polymorphisms C-174G and A-598G with Type 2 Diabetes
J. Clin. Endocrinol. Metab., October 1, 2004; 89(10): 5053 - 5058.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
J. A. McKenzie, E. P. Weiss, I. A. Ghiu, O. Kulaputana, D. A. Phares, R. E. Ferrell, and J. M. Hagberg
Influence of the interleukin-6 -174 G/C gene polymorphism on exercise training-induced changes in glucose tolerance indexes
J Appl Physiol, October 1, 2004; 97(4): 1338 - 1342.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
G. B. Di Gregorio, L. Hensley, T. Lu, G. Ranganathan, and P. A. Kern
Lipid and carbohydrate metabolism in mice with a targeted mutation in the IL-6 gene: absence of development of age-related obesity
Am J Physiol Endocrinol Metab, July 1, 2004; 287(1): E182 - E187.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
K. Ueki, T. Kondo, and C. R. Kahn
Suppressor of Cytokine Signaling 1 (SOCS-1) and SOCS-3 Cause Insulin Resistance through Inhibition of Tyrosine Phosphorylation of Insulin Receptor Substrate Proteins by Discrete Mechanisms
Mol. Cell. Biol., June 15, 2004; 24(12): 5434 - 5446.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
D. Mozaffarian, T. Pischon, S. E Hankinson, N. Rifai, K. Joshipura, W. C Willett, and E. B Rimm
Dietary intake of trans fatty acids and systemic inflammation in women
Am. J. Clinical Nutrition, April 1, 2004; 79(4): 606 - 612.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Mohlig, H. Boeing, J. Spranger, M. Osterhoff, A. Kroke, E. Fisher, M. M. Bergmann, M. Ristow, K. Hoffmann, and A. F. H. Pfeiffer
Body Mass Index and C-174G Interleukin-6 Promoter Polymorphism Interact in Predicting Type 2 Diabetes
J. Clin. Endocrinol. Metab., April 1, 2004; 89(4): 1885 - 1890.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
H.-J. Kim, T. Higashimori, S.-Y. Park, H. Choi, J. Dong, Y.-J. Kim, H.-L. Noh, Y.-R. Cho, G. Cline, Y.-B. Kim, et al.
Differential Effects of Interleukin-6 and -10 on Skeletal Muscle and Liver Insulin Action In Vivo
Diabetes, April 1, 2004; 53(4): 1060 - 1067.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
J. C. Pickup
Inflammation and Activated Innate Immunity in the Pathogenesis of Type 2 Diabetes
Diabetes Care, March 1, 2004; 27(3): 813 - 823.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
M. Wolf, J. Sauk, A. Shah, K. Vossen Smirnakis, R. Jimenez-Kimble, J. L. Ecker, and R. Thadhani
Inflammation and Glucose Intolerance: A prospective study of gestational diabetes mellitus
Diabetes Care, January 1, 2004; 27(1): 21 - 27.
[Abstract] [Full Text] [PDF]


Home page
J. Gerontol. A Biol. Sci. Med. Sci.Home page
S. M. Roth, M. A. Schrager, M. R. Lee, E. J. Metter, B. F. Hurley, and R. E. Ferrell
Interleukin-6 (IL6) Genotype Is Associated With Fat-Free Mass in Men But Not Women
J. Gerontol. A Biol. Sci. Med. Sci., December 1, 2003; 58(12): B1085 - 1088.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
A. Kubaszek, J. Pihlajamaki, V. Komarovski, V. Lindi, J. Lindstrom, J. Eriksson, T. T. Valle, H. Hamalainen, P. Ilanne-Parikka, S. Keinanen-Kiukaanniemi, et al.
Promoter Polymorphisms of the TNF-{alpha} (G-308A) and IL-6 (C-174G) Genes Predict the Conversion From Impaired Glucose Tolerance to Type 2 Diabetes: The Finnish Diabetes Prevention Study
Diabetes, July 1, 2003; 52(7): 1872 - 1876.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
J. M. Fernandez-Real and W. Ricart
Insulin Resistance and Chronic Cardiovascular Inflammatory Syndrome
Endocr. Rev., June 1, 2003; 24(3): 278 - 301.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
C. Belluco, F. Olivieri, M. Bonafe, S. Giovagnetti, E. Mammano, R. Scalerta, A. Ambrosi, C. Franceschi, D. Nitti, and M. Lise
-174G>C Polymorphism of Interleukin 6 Gene Promoter Affects Interleukin 6 Serum Level in Patients with Colorectal Cancer
Clin. Cancer Res., June 1, 2003; 9(6): 2173 - 2176.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. M. Fernandez-Real, M. Broch, C. Richart, J. Vendrell, A. Lopez-Bermejo, and W. Ricart
CD14 Monocyte Receptor, Involved in the Inflammatory Cascade, and Insulin Sensitivity
J. Clin. Endocrinol. Metab., April 1, 2003; 88(4): 1780 - 1784.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
A. Kubaszek, J. Pihlajamaki, K. Punnonen, P. Karhapaa, I. Vauhkonen, and M. Laakso
The C-174G Promoter Polymorphism of the IL-6 Gene Affects Energy Expenditure and Insulin Sensitivity
Diabetes, February 1, 2003; 52(2): 558 - 561.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
F. Wieser, G. Fabjani, C. Tempfer, C. Schneeberger, M. Sator, J. Huber, and R. Wenzl
Analysis of an Interleukin-6 Gene Promoter Polymorphism in Women With Endometriosis Polymorphism in Women With Endometriosis By Pyrosequencing
Reproductive Sciences, January 1, 2003; 10(1): 32 - 36.
[Abstract] [PDF]


Home page
DiabetesHome page
J. J. Senn, P. J. Klover, I. A. Nowak, and R. A. Mooney
Interleukin-6 Induces Cellular Insulin Resistance in Hepatocytes
Diabetes, December 1, 2002; 51(12): 3391 - 3399.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
N. S. Jenny, R. P. Tracy, M. S. Ogg, L. A. Luong, L. H. Kuller, A. M. Arnold, A. R. Sharrett, and S. E. Humphries
In the Elderly, Interleukin-6 Plasma Levels and the -174G>C Polymorphism Are Associated With the Development of Cardiovascular Disease
Arterioscler. Thromb. Vasc. Biol., December 1, 2002; 22(12): 2066 - 2071.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. Esposito, F. Nappo, R. Marfella, G. Giugliano, F. Giugliano, M. Ciotola, L. Quagliaro, A. Ceriello, and D. Giugliano
Inflammatory Cytokine Concentrations Are Acutely Increased by Hyperglycemia in Humans: Role of Oxidative Stress
Circulation, October 15, 2002; 106(16): 2067 - 2072.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J.-M. Fernandez-Real, M. Pugeat, M. Grasa, M. Broch, J. Vendrell, J. Brun, and W. Ricart
Serum Corticosteroid-Binding Globulin Concentration and Insulin Resistance Syndrome: A Population Study
J. Clin. Endocrinol. Metab., October 1, 2002; 87(10): 4686 - 4690.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
M. A. FEBBRAIO and B. K. PEDERSEN
Muscle-derived interleukin-6: mechanisms for activation and possible biological roles
FASEB J, September 1, 2002; 16(11): 1335 - 1347.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
H. Wang, W. S. Chu, C. Hemphill, and S. C. Elbein
Human Resistin Gene: Molecular Scanning and Evaluation of Association with Insulin Sensitivity and Type 2 Diabetes in Caucasians
J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2520 - 2524.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
G. Villuendas, J. L. San Millan, J. Sancho, and H. F. Escobar-Morreale
The -597 G->A and -174 G->C Polymorphisms in the Promoter of the IL-6 Gene Are Associated with Hyperandrogenism
J. Clin. Endocrinol. Metab., March 1, 2002; 87(3): 1134 - 1141.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
B. Vozarova, C. Weyer, R. S. Lindsay, R. E. Pratley, C. Bogardus, and P. A. Tataranni
High White Blood Cell Count Is Associated With a Worsening of Insulin Sensitivity and Predicts the Development of Type 2 Diabetes
Diabetes, February 1, 2002; 51(2): 455 - 461.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J.-M. Fernandez-Real, M. Vayreda, C. Richart, C. Gutierrez, M. Broch, J. Vendrell, and W. Ricart
Circulating Interleukin 6 Levels, Blood Pressure, and Insulin Sensitivity in Apparently Healthy Men and Women
J. Clin. Endocrinol. Metab., March 1, 2001; 86(3): 1154 - 1159.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2000 by the American Diabetes Association.